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ABSTRACT
The overall aim of this thesis has been to investigate the prognostic value of exercise capacity 
and whether a multifactorial rehabilitation program could affect traditional cardiac risk 
factors as well as self-rated health, quality of life, depression, anxiety, hospital utilization and 
sickness absenteeism in women younger than 66 years with coronary artery disease (CAD).
Study I
Evaluation of the role of exercise capacity and how physical capacity, leisure time and 
physical activity influence long term all-cause and cardiovascular mortality. A follow-up 
nine years after the coronary event showed that sedentary lifestyle, low physical fitness, 
inadequate blood pressure and heart rate response during exercise test were independent 
predictors for all-cause mortality as well as cardiovascular mortality. 
Study II
To evaluate whether a five-year long randomized controlled trial (RCT) rehabilitation 
program for women <66 years with CAD had effect on the use of hospital care (official data) 
and self-reported sick leave. After 5 years the intervention group had reduced their visits at 
emergency wards significantly more than the control group. There were no differences in sick 
leave rates between the groups.
Study III
In the same RCT population as in study II, exercise capacity and psychosocial factors were 
measured yearly during five years. Exercise capacity remained unchanged during the five 
years and no differences between the intervention and control group was found. Additionally, 
no differences between the groups were seen in psychosocial factors, however, several of 
these factors were improved in both groups. In a 10-14 years follow-up questionnaire both 
groups reported improved quality of life compared with baseline, but not compared with five 
years. A better trust in future quality of life was seen in the intervention group compared to 
controls. Depressive symptoms were equally decreased in both groups while symptoms of 
anxiety were unchanged.
Study IV
Occurence of baseline depressive symptoms and its relation to angina pectoris (AP) in the 
women included in study II were investigated. Moderate to severe depression (BDI >19) 
were strongly correlated to established AP (p<0.01) and higher rates of anxiety, indicating 
that anxiety is a noteworthy symptom in depressed CAD women. Depressed women were 
also more likely to have a family history of heart disease and were less likely to care about 
their future health.
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SAMMANFATTNING
Det övergripande syftet med denna avhandling har varit att undersöka det prognostiska 
värdet av fysisk arbetsförmåga och hur ett långsiktigt rehabiliteringsprogram kan påverka 
fysisk kapacitet, sjukskrivning, sjukhusvård, livskvalitet, depression, ångest och kardiella 
riskfaktorer hos kvinnor yngre än 66 år med kranskärlssjukdom (CAD).
Studie I
Utvärdering av betydelsen av fysisk kapacitet (konditionen) och hur graden av motion påverkar 
överlevnad hos kvinnor med hjärt-kärlsjukdom. Inaktiv livsstil och låg arbetsförmåga gav 
sämre prognos för överlevnad.
Studie II
Utvärdering av  hur ett fem år långt rehabiliteringsprogram för kvinnor yngre än 66 år med 
kranskärlssjukdom påverkat graden av akut sjukhusvård och sjukfrånvaro jämfört med en 
kontrollgrupp. Efter 5 år hade interventionsgruppen lägre grad av akut sjukhusvård än kon-
trollgruppen. Det fanns ingen skillnad i sjukskrivningsgrad mellan grupperna.
Studie III
I denna studie undersöktes huruvida rehabiliteringsprogrammet som genomfördes i studie 
II hade effekter på fysisk kapacitet, hjärtsymtom och psykosociala faktorer årligen under 
5 år. Arbetskapaciteten förblev oförändrad och inga skillnader mellan interventions- och 
kontrollgrupp hittades. De första fem åren sågs ingen skillnad mellan grupperna avseende 
psykosociala faktorer.
10-14 år efter studiestart skickades en förkortad version av tidigare enkät ut. 
Interventionsgruppen skattade sin framtida livskvalitet högre jämfört med kontrollgruppen. 
Depressiva symtom minskade i samma grad i båda grupperna.
 
Studie IV
Sambandet mellan depressiva symtom och kärlkramp studerades hos de kvinnor som inick i 
studie II. Måttlig till svår depression hade ett starkt samband med graden av kärlkramp och 
ångest. Deprimerade kvinnor var mindre benägna att bry sig om sin framtida hälsa samt hade 
högre grad av ärftlig belastning för hjärt-kärlsjukdom. 
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ABBREVIATIONS
ACS  Acute Coronary Syndrome
ACE  Angiotensin-converting Enzyme Inhibitors
AP Angina Pectoris
Apo A1 Apolipoprotein A1
Apo B1 Apolipoprotein B1
BMI  Body Mass Index
AMI Acute Myocardial Infarction
ANOVA Analysis of Variance
BDI  Becks Depression Inventory 
BAI Becks Anxiety Inventory
CABG Coronary Artery Bypass Grafting
CAD Coronary Artery Disease
CBT Cognitive Behavior Therapy
CVD Cardiovascular Disease
CHD  Coronary Heart Disease
CR Cardiac Rehabilitation
DM Diabetes Mellitus
ECG Electrocardiogram
EU European Union
ET Exercise Test
GNP Gross National Product
HAD Hospital Anxiety, Depression scale
HDL High Density Lipoprotein
HR Heart Rate
HT Hormone Therapy
ICD International Classification of Diseases
LDL Low Density Lipoprotein
PCI Percutaneus Coronay Intervention
QoL Quality of Life
RPP Rate Pressure Product
SBP Systolic Blood Pressure
SD  Standard Deviation
SRH Self Rated Health
TG Triglycerides
UAP Unstable Angina Pectoris
WHR Waist to Hip circumference Ratio
Agneta Andersson
10
INTRODUCTION
Epidemiology
Cardiovascular disease (CVD) including coronary artery disease (CAD), ischemic heart 
disease (IHD) and stroke, is the most common cause of death for both women and men in 
the Western world. Psychosocial factors are associated with increased risk for myocardial 
infarction (MI) (Rosengren, Hawken et al. 2004). The risk factors for MI are shared by women 
and men but might have different impact (Lundberg 2000). In women CAD is manifested 
9-20 years later (Flavell 1994; Moore 1996; Graves and Miller 2003). Women have still some 
disadvantages compared with men in time to diagnose, treatment, medication, prognosis and 
cardiac rehabilitation (Mosca, Appel et al. 2004; Stramba-Badiale, Fox et al. 2006; Graham, 
Atar et al. 2007).
Risk factors in women
Background
Management of women’s health seldom includes CVD prevention, in spite of CVD being the 
most common cause of death in females. A possible reason may be that CVD has traditionally 
been perceived as a “man’s illness”. Since many deaths from CVD can be prevented also in 
women, it is of utmost importance that there is more general awareness about CVD in women 
and that cardiac rehabilitation is offered also to women. According to the INTERHEART 
study (Yusuf, Hawken et al. 2004), nine factors are responsible for 90% of all cases of CVD. 
These factors are dyslipidemia, hypertension, smoking, stress, diabetes, obesity (especially 
abdominal fat distribution), physical inactivity, poor diet with insufficient fruit and vegetable 
intake and degree of alcohol consumption. CVD presents 10 years later in women, who are 
therefore older and more likely to suffer from comorbidities such as diabetes and hypertension. 
The difference in age at CVD onset is largely explained by higher levels of risk factors at 
younger ages in men compared with women (Yusuf, Hawken et al. 2004; Anand, Islam et al. 
2008).
Premature menopause, gestational diabetes, gestational hypertension, pre-eclampsia, 
complications at birth, polycystic ovarian syndrome are suggested to be special female risk 
factors for future CVD (Shaw, Bairey Merz et al. 2008; Drost, Maas et al. 2010; Vujovic, 
Brincat et al. 2010).
The protective role of female sex hormones on cardiovascular disease has been debated for 
decades and publications arising from large prospective, randomized controlled trials (RCT) 
at the beginning of this millennium reduced prescriptions of systemic menopausal hormone 
therapy (HT) (Hulley, Grady et al. 1998). Today, most cardiologists tend to discontinue 
HT as soon as a woman has had a cardiac event, irrespective of the indications such as 
early menopause or control of severe climacteric symptoms. Various types of HT have 
different actions on the cardiovascular system, lipid metabolism and coagulation factors. A 
comprehensive risk-benefit evaluation should be performed for each woman on HT (Schenck-
Gustafsson, Brincat et al. 2011).
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In Europe, the SCORE system (Conroy, Pyorala et al. 2003) is used to evaluate CVD risk. 
However, this system only goes up to the age of 65 years and will thus miss many women. 
While guidelines are based on traditional risk factors, cardiac events do not necessarily occur 
in women with these risk factors. The same risk factors for both sexes have been used in risk 
calculations for the last 40 years in spite of increasing knowledge about gender differences. 
Lipids
In women, as well as in men, the association between total cholesterol and LDL-cholesterol 
with increased cardiac risk is beyond dispute, as are the benefits of its reduction in high-risk 
individuals. The follow-up study by the Lipid Research Clinic demonstrated that low HDL-C 
was the most significant predictor of death from IHD in women, after being adjusted for age 
(Jacobs, Mebane et al. 1990). Recent publications support the fact that there is no evidence 
for lipid lowering treatment in healthy women or men without known risk factors. In patients 
with known risk factors or established CVD, the evidence show treatment benefits in both 
genders (Walsh and Pignone 2004; Baigent, Blackwell et al. 2010; Reiner, Catapano et al. 
2011).
The Swedish National Guidelines (2008) propose a total cholesterol target of less than 5 
mmol/L for primary prevention and less than 4.5 mmol/L for secondary prevention. Low 
HDL levels have been found in epidemiological studies to have a greater impact in women 
than in men, but intervention studies independently focused on HDL are difficult to design 
(Legato 2000). However, there are some ongoing clinical trials with drugs which increase 
HDL. Most recent guidelines recommend treatment for those with concentrations below 1 
mmol/L. An increase of 1% in HDL is associated with 3-5% decrease in CVD risk in women, 
but only 2% in men. In women, hypertriglyceridemia is an independent risk factor for CVD, 
while among men this remains an ongoing debate. A change of lifestyle including weight 
reduction and increased physical activity is recommended (Baigent, Blackwell et al. 2010).
In the two major secondary prevention trials involving significant enough numbers of women, 
lipid-lowering therapy benefited women to an even greater extent than men (Baigent, Landray 
et al. 2011; Kostis, Moreyra et al. 2011). In the simvastatin arm of the MRC/BHF Heart 
Protection Study (2002), there was a significant reduction in all-cause mortality and a 24% 
reduction in vascular events, women had the same benefits as men. All other statin studies 
have calculated the risk for women post hoc as a subgroup analysis, and the results should 
be interpreted cautiously (Aulakh and Anand 2007). Other agents include nicotinic acid, 
ezetimibe and fibric acid derivates (gemfibrozil and fenofibrate); however, gender-specific 
outcomes with these agents have not been reported.
Hypertension
A meta-analysis of prospective data collected from over 1 million adults (40-69 years) has 
shown that a 20 mmHg systolic or a 10 mmHg diastolic increase in blood pressure (BP) 
doubles the mortality from CVD (Lewington, Clarke et al. 2002). A three-fold increase 
in CVD and stroke is found in women with a systolic BP >185mmHg as compared with 
women with systolic BP <135mmHg. Van der Giezen recommends BP <140/90mmHg in all 
hypertensive patients and <130/80mmHg in diabetics or other groups with high cardiovascular 
risk, a target agreed upon by most national societies (van der Giezen, Schopman-Geurts van 
Kessel et al. 1990). The treatment of hypertension is currently the same for both genders 
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with, in most cases, pharmacotherapy along with lifestyle changes. The first-line drugs are 
angiotensin-converting enzyme ACE inhibitors (or, if not tolerated, angiotensin-receptor 
blockers, ARBs), diuretics and calcium-channel blockers. When the response is inadequate, 
other medications like beta-receptor blockers can be employed. Women report more cough 
with ACE inhibitors and peripheral edema with calcium-channel blockers.
Smoking
That smoking predisposes atherosclerosis and major cardiovascular events also in women 
is indisputable (Doll, Peto et al. 2004; Huxley and Woodward 2011). In the Nurses Health 
Study, including over 120 000 healthy nurses, four to five cigarettes a day almost doubled 
the risk and 20 cigarettes a day increased the risk six times (Sarna, Bialous et al. 2008). The 
reduction of smoking has been a worldwide public health achievement; however, the number 
of smoking women (initially lower than men) has not declined to the same extent as smoking 
men. This is particularly true for younger women, leading to significant vascular problems in 
later life. The INTERHEART study (Yusuf, Hawken et al. 2004) estimated that 29% of heart 
attack cases in Western Europe are due to smoking; and smokers and former smokers are at 
almost twice the risk of a heart attack compared with non-smokers (Rosengren, Hawken et 
al. 2004). Women have more difficulties to stop smoking, one of the reasons could concern 
weight gain. Cigarette smoking decreases the endogenous levels of estrogen in women, and 
increases the risk of premature menopause, which in itself is a predisposing factor for CVD. 
The adverse effect of smoking is related to the amount and duration of the abuse and smoking 
induces more powerful cardiovascular effects in women than in men. One possible reason 
is that the dimensions of the heart and lung are smaller in women, and therefore the same 
amount of smoking might be more harmful to female than to male organs (Njolstad, Arnesen 
et al. 1996; Woodward, Lam et al. 2005). In smoking patient’s comorbidities like diabetes 
and hypertension will accelerate the atherosclerotic process. 
Diabetes
Cardiovascular events are the leading cause of death especially in type II diabetes, and 
diabetic women have a 3 to 5-fold increased risk of developing CVD compared with men 
(Garcia, McNamara et al. 1974).
The INTERHEART study estimated that 15% of the heart attacks in Western Europe are due 
to diagnosed diabetes (Rosengren, Hawken et al. 2004). The corresponding figure in Central 
and Eastern Europe is 9%. In the Nurses’ Health Study, CHD mortality in women with 
diabetes was 8.7 times higher than in non-diabetics, and in addition, those who had a known 
history of CHD had a relative risk of 25.8 for fatal coronary artery disease (Hu, Stampfer et 
al. 2001). In the Copenhagen City Heart Study including 7198 women over a 20-year period, 
the relative risk of a new myocardial infarction among diabetics was 1.5-4.5 compared 
with non-diabetics (Almdal, Scharling et al. 2004). In addition, diabetic women develop 
CVD earlier and at the same ages as men compared to non-diabetic women. According to 
a recent study, diabetic women below 65 years of age have poorer outcomes than diabetic 
men after myocardial infarction, and this relates probably to an increased risk factor burden 
(Norhammar, Stenestrand et al. 2008). The frequency and severity of atherosclerotic disease 
in diabetes have led to several recent guidelines to assign the condition as a coronary heart 
disease equivalent, justifying aggressive intervention.
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Obesity
Overweight and obesity together with physical inactivity contribute to 15% of all deaths 
(Yusuf, Hawken et al. 2004). The relation between body size and body weight is expressed 
in body-mass index (BMI), calculated as weight in kilograms divided by the square of height 
in meters. BMI >25 is regarded as overweight and a BMI of >30 as obesity. Obesity is 
often correlated to impaired insulin sensitivity and impaired endothelial function. Abdominal 
obesity is a risk factor for impaired glucose intolerance, diabetes and myocardial infarction. 
The risk for metabolic diseases is increased with a waist circumference of greater than 80 
cm in women and 94 cm in men. Much evidence has focused on the distribution of fat with a 
more android morphology (apple) representing a higher cardiac risk than a more gynaecoid 
(pear) shape (Yarnell, Patterson et al. 2001). Viceral fatty tissue is playing a central role in 
lipid and glucose metabolism.
One of the outcomes noted in the Nurses’ Health Study was that there is a gradient of coronary 
risk, with the heaviest category of women having a 3-fold increased risk for CVD compared 
with lean women (Manson, Willett et al. 1995).
Exercise and physical activity
In a prospective observational study, it was found that a lower level of fitness was associated 
with a 4.7-fold increased risk of myocardial infarction and stroke, independent of other 
vascular risk factors (Blair, Kohl et al. 1989). The reported beneficial effects of exercise on 
CVD risk profile are less marked in women than in men, with smaller increases in HDL and 
weight loss resulting from similar exercise training (Bush, Fried et al. 1988). Nevertheless, 
in the Nurses’ Health Study, two aspects were particularly important: brisk walking conferred 
the same benefit as vigorous exercise, and sedentary women who became active late in life 
had similar benefits as those who were active throughout their life span (Manson, Hu et al. 
1999). The recommended level of physical activity is a minimum of 30 min brisk walking 
daily (Mosca, Banka et al. 2007).
Stress
Psychosocial factors have been shown to account for approximately 30% of the attributable 
risk of AMI (Rosengren, Hawken et al. 2004). Stress at work as well as at home were more 
common among the patients with MI than in the controls in this study. Several psychosocial 
interventions have been shown to have beneficial effects on distress and physiological risk 
factors (Linden, Stossel et al. 1996; Blumenthal, Sherwood et al. 2005).
Depression and anxiety are both aspects of psychosocial stress and are independent risk 
factors both in women and men. Women with CAD, compared with men, have more problems 
with anxiety and depression, both before and after a myocardial infarction (Frasure-Smith, 
Lesperance et al. 1999; Graves and Miller 2003). Consequently, depression is considered to 
be a more important risk factor for women compared with men (Naqvi, Naqvi et al. 2005; 
Doering, McKinley et al. 2011). Therefore, rehabilitation programs aiming at reducing 
psychosocial stress may be especially effective in female CAD patients. Stress management 
in cardiac rehabilitation has recently been reviewed (Rees, Bennett et al. 2004; Linden, 
Phillips et al. 2007), but it is still not properly evaluated for women. Nevertheless, there 
are several dimensions within the broader definition of psychosocial factors that are now 
associated with an increased risk of myocardial infarction in women. For example, family 
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stress including marital stress has been shown to increase the risk of ischemic heart disease 
(Orth-Gomer, Wamala et al. 2000).
Consequently, patients with myocardial infarction should be screened for depression during 
hospital stay (Lisspers, Nygren et al. 1997). The validated version of Hospital Anxiety 
Depression scale (HAD) (Zigmond and Snaith 1983) is useful to detect anxiety and depression 
in cardiac patients and also a tool to follow up intervention therapies. The treatment of 
post-MI depression is recommended to include both selective serotonin reuptake inhibitors 
(SSRIs) and Cognitive behavioral therapy (CBT).
The ENRICHD (Enhancing Recovery in Coronary Heart Disease) study, a RCT study, 
included CBT for CAD patients with emphasis on depression and social isolation. The main 
findings in this study were modestly decreased depression and increased social support in the 
therapy group when compared to the controls (Berkman, Blumenthal et al. 2003).
Low social-economic status is associated with CAD in both women and men and seems to 
be linked to unhealthy lifestyle patterns such as smoking, higher consumptions of sugar and 
saturated fat as well as increased stress in some reports (Brezinka 1995; Wamala, Murray et 
al. 1999). 
It is also reported that women have frequent symptoms such as sleep disturbance, fatigue, and 
shortness of breath as signs of psychosocial stress (McSweeney, Cody et al. 2003). In both 
sexes, stress can not only induce, but also worsen CVD, by increasing atherosclerosis and 
pro-coagulation. It can cause negative inflammatory response and endothelial dysfunction as 
well as micro-macro vascular dysfunction.
Alcohol
While a moderate intake of alcohol may be protective, too much is deleterious for both women 
and men (Gunzerath, Faden et al. 2004; Fagrell 2006). Moderate intake of alcohol may also 
have some protective effect in women against the development of atheromatosis, measured 
with QCA- technique in connection with coronary angiography (Janszky, Mukamal et al. 
2004).
However, the protective effect of alcohol has a low grade of evidence because of the obvious 
risks in undertaking RCT studies. In addition, the control group may include former alcoholics 
who are now teetotalers. The type of alcohol is not as important as drinking pattern. A low-
to-moderate regular daily intake can be protective, while excessive drinking can be harmful 
to the heart and the liver. Recommendations are difficult but there is no reason to ask people 
to stop moderate drinking after a myocardial infarction. Conversely, it is not necessary to 
recommend people to start drinking in order to prevent CVD or further MI if they do not wish 
to. Light to-moderate alcohol intake is defined as one standard glass daily for women and two 
for men, as women metabolize alcohol more slowly than men. A standard glass is defined as 
12 g alcohol, which is equivalent to 15 cl of wine (www.socialstyrelsen.se).
Diet
The beneficial effects of the Mediterranean diet, which includes high proportions of fruit 
and vegetables, on total cholesterol, LDL cholesterol, blood pressure and MI are well 
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known (Knoops, de Groot et al. 2004). In the secondary prevention study, “Lyon Heart”, 
600 women and men were randomized to the Mediterranean diet or to a control group, after 
27 months significant differences were found in mortality and morbidity, for CVD as well 
as total mortality in favor of the Mediterranean diet (de Lorgeril, Renaud et al. 1994). The 
mechanisms behind these beneficial effects are multiple, and diet should always be combined 
with other lifestyle changes, such as exercise as well as medication when necessary.
Guidelines and inclusion of women in trials
American Heart Association (AHA) has produced special guidelines (Mosca 2007; Mosca, 
Benjamin et al. 2011) for prevention of CVD in women. In 2006, the European Society of 
Cardiology wrote a policy document (Stramba-Badiale, Fox et al. 2006) pointing out the 
importance of sex and gender analysis in CVD. This resulted in a meta-analysis (Stramba-
Badiale 2010) of all scientifically accurate articles published about CVD and its treatment 
between 2006 and 2010. The main message was that there were too few women included in 
most of the clinical trials in relation to the prevalence of the disease (ischemic heart disease, 
heart failure, diabetes mellitus, atrial fibrillation, stroke, dyslipidemias, and anticoagulant 
therapy) and there were gender analysis of the results in only 50% of the articles.
In a systematic review of CR trials, few of the patients enrolled were women (Limacher 
1998) and a Cochrane review of CR reported that 11% of the patients enrolled were women 
(Jolliffe, Rees et al. 2001).
Cardiac rehabilitation in women
 
The general goals of cardiac rehabilitation (CR) are to restore physical and physiological 
well-being. Life-style changes include smoking cessation, physical activity at least 30min 
walking/day, weight-loss if overweight, normal lipid levels and normal blood pressure. An 
early diagnosis of diabetes mellitus is essential. The best way to diagnose diabetes and pre-
diabetes is to perform an oral glucose tolerance test (B-glucoce 2h after an oral intake of 1.75 
grams glucose per kilograms body weight (normal <7.8 mmol/L)) (Bartnik, Malmberg et al. 
2004).
There is good evidence that patients after myocardial infarction should maintain treatment 
with aspirin, beta-blockers, statins and also ACE-inhibitors. All these medications have a 
recommendation class 1 and Evidence level A. Levels of evidence A are data derivated from 
multiple randomized clinical trials or meta analyses. 
Non-adherence to evidence based treatment after acute coronary syndrome will increase 
all cause mortality and readmissions. Thus, an important goal of cardiac rehabilitation is 
also to give the patients good knowledge and motivation in order to be compliant with their 
medications. Cardiac rehabilitation is a class 1 recommendation in most current clinical 
practice guidelines. However, according to a recent review (Braverman 2011), cardiac 
rehabilitation are vastly underused.
Agneta Andersson
16
CR was originally developed in the 1970´s with special regard to the needs of middle-aged 
men to promote return to work post-myocardial infarction (Limacher 1998). Despite the 
preponderance of evidence on the numerous benefits of traditional CR, it remains largely 
under-utilized in women. Studies of the effectiveness of CR have generally revealed no major 
differences between women and men (Lavie and Milani 1995). However, female-specific data 
are lacking on the effect of CR on mortality and morbidity (Sanderson and Bittner 2005). The 
reason for no reduction in cardiovascular death rates in women could be the limited number 
and size of existing studies. There are also a limited number of studies of women’s outcome 
post-CR that have been positive (Oldridge, LaSalle et al. 1980; Winberg and Fridlund 2002; 
Grace, Grewal et al. 2008; Sanderson, Shewchuk et al. 2010). Unfortunately, this literature 
suffers from low sample sizes, and lack of randomization and control groups.
In a study from United States and Canada (Grace, Abbey et al. 2002) only approximately 
15-30% of eligible patients participated in CR, with the rate for women being much lower, 
approximately 11–20% (Jackson, Leclerc et al. 2005). It has also been shown that the 
percentage of women in CR is 20% lower than what would be expected based on coronary 
morbidity data (Schuster and Waldron 1991; Radley, Grove et al. 1998). 
It is well-established that women are less likely to adhere to CR than men, the degree and 
pattern of women’s CR adherence remains incompletely understood. The reasons why women 
are missing from CR programs are multifactorial and include health care system as well as 
provider and patient-level factors (Sanderson, Shewchuk et al. 2010). 
As the traditional model of CR care is a hospital-based mixed-gender program, women are 
in the minority in such programs. Women also report perceiving these programs as male-
oriented and failing to meet their care preferences (Moore 1996). Women report being the 
only woman in a group of men, most of whom younger than themselves. The programs are 
sometimes being perceived as a “men’s club” (Radley, Grove et al. 1998). It has also been 
suggested that women may find a CR program more appealing if there is a more pronounced 
psychological emphasis like stress modification, than is currently the case (Dafoe and Huston 
1997). Thus, women may be less likely to participate in CR if they do not perceive that the 
programs meet their needs (Daly, Sindone et al. 2002). Probably women may benefit from 
alternative and novel CR approaches (Bjarnason-Wehrens, Grande et al. 2007) although this 
contention should be further studied.
There is some evidence that it is more important for women than for men to share experiences 
and with other women in the same situation in the rehabilitation situation (Davidson, Daly 
et al. 2003). Traditional programs tend to not focus enough on psychological and social 
consequences of a coronary event. In gender-mixed groups women tend to hold in their 
own feelings (Burell and Granlund 2002). Women are more likely to take care of others, 
like children and parents, and neglect their own health. These factors might contribute to the 
observed low attendance among women in cardiac rehabilitation programmes.
Sick leave
Diagnostics and treatment of CAD have improved markedly in Sweden since the 1960’s and 
the knowledge about impacts of risk factors has increased the engagement of both primary 
and secondary prevention. This has led to a decreased morbidity and mortality (more in men), 
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as well as fewer patients at working ages having heart failure-related dysfunction and that 
Swedish people are older when contracting CAD. In 2004, Perk et al reviewed the current 
knowledge of patients returning to work after CVD (Perk and Alexanderson 2004). The 
authors concluded: “The duration of sick leave due to CVD in Sweden is longer than in other 
countries, although there is no scientific evidence to support this practice”.
In spite of these facts, no major effects were seen in the frequency of sick leave up to 2007. The 
impact of the recommendations from 2007 (Swedish National Board of Health and Welfare), 
concerning the length of sick leave has recently been evaluated. A total decrease of about 
10% for women and 6% for men in all areas was reported 2011 (www.forsakringskassan.se), 
but in CVD, the changes were not so pronounced.
In the report from the Swedish National Board of Health and Welfare , the effect on sick leave 
after different forms of CR was investigated. No major effects of different types of CR were 
found.
In a Swedish RCT study (Hedback, Perk et al. 1992), a post CABG population with 3 months 
physical training program in combination with a home training program no effects on sick 
leave duration was reported. Another Swedish study (Lisspers, Hofman-Bang et al. 1999), 
reported no effects on return to work after a special residential CR program, in patients 
having had a PCI, in spite of a proven positive effect on risk factors. PCI-patients had shorter 
sick leave periods immediately after the intervention compared to CABG-patients but in the 
long-term there was no difference.
Which are the predisposing factors for medically unmotivated sick leave time and why do 
Swedish patients have longer sick leave periods than other comparable countries? In the sick 
leave research the severity of the disease including complications had a moderate impact on 
the duration of sick leave. Psychosocial factors including depression, anxiety and poor self-
confidence negatively influenced return to work after myocardial infarction. (Maeland and 
Havik 1986; Maeland and Havik 1987) The patients own perception for the disease was an 
obstacle for returning to work (Petrie, Weinman et al. 1996).
Also demographic and social predictors might play a role. The acuteness of the disease and 
the waiting time of an intervention might also be important. Recently Lynoe et al, reported 
that positive encounters with health care personnel including feelings of respect facilitated 
self-estimated ability to return to work (Lynoe, Wessel et al. 2011). 
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AIMS OF THE THESIS
The overall objective of this research work has been to study women´s risk factors for 
coronary artery disease and to create and evaluate a cardiac rehabilitation program.
Study I
To evaluate the importance of exercise testing parameters and leisure time physical activity 
in predicting long-term prognosis in women ≤65 years, hospitalized for acute coronary 
syndrome.
Study II
The aim of this paper was to evaluate whether a five-year long rehabilitation program for 
women ≤65 years with coronary artery disease affected the use of hospital care and sickness 
absenteeism.
Study III
The aims of this study was to follow the women in the rehabilitation program (study II), 
regarding exercise tests and different aspects of health and quality of life. These factors, 
except for exercise tests, were followed up 10-14 years after study onset.
Study IV
The purpose of this study was to investigate the relation between depressive symptoms and 
angina in the women included in study II.
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MATERIAL AND METHODS
Study populations
 
Study I
In a community based study (Stockholm Female Coronary Risk Study), all females aged <66 
years that resided in the greater Stockholm area and were hospitalized for an acute coronary 
event between 1991 and 1994 were asked to participate. Inclusion was based on medical 
records indicating AMI, based on the WHO criteria of chest pain, enzyme patterns and/or 
diagnostic ECG changes. The ECG changes were based on the Minnesota code. 335 women 
were admitted. Unstable angina pectoris (UAP) was defined as new onset of angina pectoris 
or deterioration of known stable angina pectoris during the last 4 weeks before admission. 
Study II, III and IV
The subjects in studies II, III and IV were women below 66 years of age, which fulfilled 
the inclusion criteria: AMI, ACS, PCI, CABG and who were elected by referring clinicians, 
or rehabilitation teams, from all hospitals in Stockholm county council. Exclusion criteria 
were non-swedish speaking, having heart failure, unstable angina pectoris or other disabling 
diseases including drug abuse. Inclusion started in April 1997 and ended in October 2000.
Study designs and methods
Study I
A clinical screening was carried out 1-6 months after hospitalization. The screening included 
coronary angiography, exercise test and routine blood sampling including fasting lipids. 292 
patients joined the study and were able to attend the screening. Exercise tests were performed 
in 273 patients. Coronary angiograms were performed in 238 patients.
The following CVD risks were assessed:, smoking status (current, previous, or non smoker), 
clinical history of diabetes mellitus and hypertension. Blood pressure, height, weight and 
BMI were measured. Hypertension was defined as a history of systolic blood pressure 
>140 mmHg and/or a diastolic blood pressure >90 mmHg measured twice after supine rest. 
Menopausal status was defined as the absence of menstrual bleeding for at least 6 months. 
Females who had started HT were regarded as postmenopausal. Coronary angiography was 
performed according to the Judkins technique. Two independent viewers categorized left 
ventricular function as normal or dysfunctional.
Exercise tests were performed on an electrically braked bicycle (Megacart 840; Siemens 
Elema, Solna, Sweden) until fatigue or other limiting symptoms were reached. The starting 
load was on 30 watt. The work load was increased by 10 watt every minute. A continuously 
single-averaged 12-lead was recorded before and ten minutes after exercise. Cuff brachial 
artery systolic was recorded at rest and at the end of each work load every minute up to ten 
minutes after exercise. Anginal chest pain, leg fatigue and a feeling of general exhaustion 
were graded at the end of each workload using the 10-graded Borg scale (Astrom and 
Agneta Andersson
20
Jonsson 1976; Borg, Holmgren et al. 1981). Exercise-induced ST depression ≥ 1 mm at a 
time of 60 milliseconds after the J point in at least two consecutive ECG leads, were defined 
as pathological.
Physical activity (during leisure) was assessed by the patients with a questionnaire based on 
the WHO criteria (Baecke, Burema et al. 1982). The leisure time activities were graded into 
four categories that were dichotomized into “physically inactive” (sedentary lifestyle) or 
“physically active”. 
I= Reading, watching television or other sedentary leisure activities 
II= Walking, cycling or other forms of physical activity
III= Exercise to keep fit, heavy gardening, etc. for at least 4 h a week
IV= Hard training or participating in competitive sports regularly several times a week
1=  Physically inactive included the above I
2=  Physically active included the above II-IV
Study II and III 
Baseline examinations included medical history, medication, angina pectoris (Canadian class 
I-IV) (Sangareddi, Chockalingam et al. 2004) (assessment of risk factors for CAD, exercise 
test and questionnaires (adopted from a similar rehabilitation study (Lisspers, Hofman-Bang 
et al. 1999)). Fasting routine blood samples including lipids were collected. The baseline 
examinations were performed before randomization and repeated once a year for the 
following five years. 
The questionnaire covered socio-demographic factors, medical, psychosocial and 
psychological factors, bodily symptoms, sick leave and disability pension. All scales were 
previously scientifically validated.
The scale used were Quality of Life (“Ladder of life”) (Cantril 1965), SRH (Eriksson, Unden 
et al. 2001), BDI (Beck, Ward et al. 1961), BAI (Beck, Epstein et al. 1988), HAD (Zigmond 
and Snaith 1983; Lisspers, Nygren et al. 1997), The Gothenburg Quality of Life Inventory 
(Tibblin, Tibblin et al. 1990; Tibblin, Svardsudd et al. 1993), and Job decision latitude 
(Karasek, Baker et al. 1981).
For study II: The participant’s use of hospital-based health care during the studied period was 
followed via a register from the Swedish National Board of Health and Welfare. Only hospital 
visits due to CAD-related diagnosis were documented. Both scheduled and emergency visits 
at hospitals were included, and yearly numbers of in-patient days were calculated for each 
year. 
For study III: In 2011, 10-14 years after study onset, a simplified questionnaire, based on 
the one used originally, was sent to the participants. The questionnaire included Quality of 
life (Cantril 1965), HAD (Zigmond and Snaith 1983; Lisspers, Nygren et al. 1997), SRH 
(Eriksson, Unden et al. 2001) and physical symptoms. The patients also reported if any new 
cardiac event had occurred since they left the program and current medication. 
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Intervention program
The intervention program was group-based and included 6-10 women in each group. The 
premises were at Saltsjöbaden’s Hospital in the Stockholm archipelago.
The program duration was five years. The first rehabilitation course endured for 2 weeks and 
was followed by five additional days, two months later. Thereafter, the courses were held 
twice a year for two days, each occasion. All interventions were residential. 
The aims of intervention were to identify stress factors such as depression, anxiety and vital 
exhaustion. Furthermore, the aims were to inform about medication, cardiac symptoms and 
to differentiate cardiac- from other bodily and psychosomatic symptoms. This included 
in-depth interviews by a psychologist in order to identify individual problems and needs. 
Patients perceived as depressed were offered consultation with a psychiatrist associated to the 
project. The program also contained different types of physical activity in order to promote 
a healthier life style.
Psychological reactions were discussed and handled both on group- and on individual level 
during the five years. The psychosocial part of the rehabilitation was based on an interactive, 
self-instructional program called “Stress as an opportunity” (Moser and Björkegren 1998) 
that includes manuscript for the group leader and a patient orientated book to prevent stress, 
(self assessments concerning different causes of stress, homework assignments, cassette 
tape with relaxation practices and tools to create an individual action plan). The follow-up 
sessions had specific themes, e.g. burnout symptoms, type A behaviour, assertiveness, coping 
strategies and self-efficacy. The aim was to identify negative thoughts and replace them with 
more effective coping strategies. The program has previously been used and evaluated in 
work-settings (Orth-Gomer, Eriksson et al. 1994; Theorell T, Moser V et al. 1995).
Study IV
BDI is a 21 item questionnaire, often used to classify the severity of depression (Beck, Ward 
et al. 1961). Each item is scored from 0-3 (0= none to 3= severe) with a total range from 0-63. 
The questionnaire include the following symptoms: pessimistic mood, sense of failure, lack of 
satisfaction, feelings of guilt, self-hate, self-accusations, suicidality, crying spells, irritability, 
social withdrawal, indecisiveness, body image, work inhibition, sleep disturbance, fatigue, 
loss of appetite, weight loss, somatic preoccupation and loss of libido. BDI-scores ≥19 are 
regarded as mild to severe depression. 
Degree of anxiety was measured with the 21-item BAI (Beck, Epstein et al. 1988). The 
items, scored from 0=none to 3=severe, describes the following common symptoms of 
anxiety: numbness or tingling, feeling hot, wobbliness in the legs, inability to relax, fear 
of the worst thing happening, dizziness, heart pounding or racing, unsteadyness, feeling 
terrified, nervousness, chocking feeling, trembling hands, shakiness, fear of losing control, 
difficulty breathing, fear of dying, indigestion or discomfort in the abdomen, flushed face 
and sweating. 
Sociodemographic factors, anxiety rate, history of heart disease, hereditary cardiovascular 
disease, prescribed medication, biochemical variables, risk factors for CAD, lifestyle habits, 
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and attitudes to lifestyle changes, were compared in women with a BDI score ≥19 versus 
those with a BDI score <19. 
Assessment of lifestyle: To measure lifestyle habits and attitudes toward lifestyle changes, 
a number of questions were used that examined aspects of self-rated health, belief in the 
importance of taking care of one’s health, now and in the future, current lifestyle and attitude 
to lifestyle changes. The scales had been previously used in a Swedish rehabilitation program 
for patients with coronary artery disease (Lisspers, Hofman-Bang et al. 1999).
Blood chemistry: A hospital research nurse obtained fasting morning blood samples through 
an indwelling catheter. Venous blood was drawn into Vacutainer tubes to obtain serum. Total 
serum cholesterol and triglycerides were determined with Ektachem dry chemistry (Johnsson 
& Johnsson, New Brunswick, New Jersey). HDL was determined with enzymatic methods 
using reagents (Boehringer Mannheim GmbH, Mannheim, Germany). LDL was calculated 
with the Friedewald formula. S-apolipoprotein A1 (Apo A1), S-apolipoprotein B (Apo B) 
and S-lipoprotein (a) were determined with immunephelometry using reagents (Beckman 
Coulter, Inc., Fullerton, California). 
Statistical methods
Study I 
Comparisons of continuous variables amongst different groups were made by using Mann-
Whitney U Test. Chi2 test was used to compare categorical data. Cox proportional hazard 
model was used to compare categorical data and to assess the relative importance of exercise 
parameters in predicting mortality. Univariate analyses were performed first. Each exercise 
parameter was entered separately as a continuous variable. Hazard ratios (HR) with confidence 
intervals were computed for each decrease in standard deviation.
Exercise test variables and sedentary lifestyle were also tested using Cox model, after 
adjustment for the potential confounders; age, BMI, coronary index event, left ventricular 
function, history of DM, smoking, serum cholesterol and use of beta-blockers.
Statistical analyses were performed using SPSS 11.5 (SPSS Inc., LEAD Technologies, 
Haddonfield, NJ, USA) and SAS 8.02 (SAS Institute Inc., Cary, NC, USA).
Study II 
Differences between the intervention group and the control group were for continues variables 
tested with t-test and for categorical variables with chi2. As data of emergency and scheduled 
hospital visits, as well as in-patient days were strongly skewed (a large portion had zero 
visits), tests were also made with dichotomized variables: visits-no visits. Result from these 
test are only presented in text. To test difference in proportion of women on sick leave, with 
early retirement and with employment chi2 were used.
Statistical analyses were performed using SPSS 11.5 (SPSS Inc., LEAD Technologies, 
Haddonfield, NJ, USA) and SAS 8.02 (SAS Institute Inc., Cary, NC, USA) and Statistica 7 
for Windows (StatSoft, Inc., Tulsa, Oklahoma).
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Study III 
As data were found to have skewed distributions, non parametric methods (Mann-Whitney 
U-test) were used to test the group differences and changes during the intervention period. 
Statistical analyses were performed with Statistica 10 for Windows (StatSoft, Inc., Tulsa, 
Oklahoma).
Study IV 
Several variables were found to have skewed distribution; a non parametric Mann-Whitney 
U-test was used when comparing groups. However, BDI and BAI items were analysed 
using parametric models such as analysis of variances (ANOVA) and multiple regression. 
Categorical variables were tested with chi2. All statistical analyses were performed with 
StatSoft Statistica 7 for Windows (StatSoft, Inc., Tulsa, Oklahoma).
Ethical considerations
The protocols and procedures were approved by the local committees for human research at 
Karolinska Hospital Ethics Committee, No 97-102 (Study I), 1997 00-093 (Study II, III, IV), 
2011/465-32 (Study III).
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RESULTS
Study I
In 292 female patients <66 years surviving CAD, important independent predictors of long-
term, all-cause mortality were studied. Left ventricular dysfunction, sedentary lifestyle, his-
tory of diabetes and hypertension were significantly more frequent amongst non-survivor 
(Table 1). Moreover, non-survivors had higher levels of triglycerides and total cholesterol. 
Sedentary lifestyle during leisure time was independently predictive of all-cause and cardio-
vascular mortality.
Table 1. Clinical characteristics of the study population
All patients 
n (%)
Survivors 
n (%)c
Non-survivors
n (%)c
P-value a
Diagnosis at index event
 AMI 110 (37) 90 (82) 20 (18) 0.08
 UAP 182 (63) 162 (89) 20 (11)
Menopausal status
 Premenopausal 74 (25) 67 (90.5) 7 (9.5) 0.35
 Postmenopausal with HRT 36 (12) 32 (89) 4 (11)
 Postmenopausal without HRT 182 (63) 153 (84) 29 (16)
Cigarette smoking
 Non smokers 92 (32) 80 (87) 12 (13) 0.91
 Previous smokers 140 (48) 121 (48.4) 19 (48.3)
 Current smokers 58 (20) 49 (19.6) 9 (22.5)
Left ventricular dysfunction 30 (15) 19 (56) 11 (32) <0.001
Sedentary lifestyle 70 (24) 55 (79) 15 (21) 0.04
Use of β-blockers 197 (66) 171 (87) 26 (13) 0.50
History of hypertension 144 (50) 129 (90) 15 (10) 0.02
History of diabetes mellitus 33 (11) 24 (73) 9 (27) 0.002
Coronary stenosis ≥50% d 150 (63) 130 (87) 20 (13) 0.66
Mean (SD) Mean (SD) Mean (SD) P-value b
Age (years) 56.7 (7) 55.7 (7.0) 57.7 (7.0) 0.06
BMI 26.9 (5) 27.1 (4.5) 26.6 (4.8) 0.43
Waist-hip ratio 0.84 (0.08) 0.84 (0.08) 0.85 (0.07) 0.48
Systolic blood pressure (mmHg) 123 (21) 121 (16) 125 (24) 0.40
Triglycerides (mmol/l) 1.77 (1.8) 1.67 (1.79) 2.42 (1.95) 0.003
Cholesterol (mmol/l) 6.49 (1.2) 6.43 (1.22) 6.87 (1.32) 0.03
HDL (mmol/l) 1.48 (0.4) 1.48 (0.54) 1.47 (0.40) 0.40
LDL (mmol/l) 4.07 (1.4) 4.09 (1.20) 3.91 (1.78) 0.93
aChi2 test, bMann-Whitney U test, cpercentage of corresponding parameter, dpercentage of lumen diameter in 
major coronary vessel
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Study II
Out of 168 referrals, 19 dropped out and 149 were randomized. Further 19 women dropped out 
after randomization, but before rehabilitation onset. 69 women were allocated to the intervention 
group and 61 women to the control group (figure 1). The main reasons for declining participation 
were family- or work-related factors.
The intervention group had higher mean ratings of depression compared with the control group 
at baseline (table 2 and 3). No other baseline differences between the groups were observed.
According to national registers: women in the intervention group showed yearly decreases of 
visits to hospital emergency wards (figure 2a). The same trend was observed in the control 
group up to the fourth year when number of emergency visits had increased. At year five, the 
intervention group had significantly less number of visits compared with controls (p<0.05). 
These differences are reflected in number of in-patient days (figure 2c). Scheduled doctor visits 
(hospital) decreased in both groups over the years (figure 2b).
Self-reported data on sick leave and disability pension showed no significant differences 
between groups after one, three and five years. 
168 Referrals
149 randomized
6 drop-outs
69 allocated to intervention
10 days + 5 days + 2 days 
in-patient rehabilitation
2 x 2 days in-patient 
rehabilitation yearly
Baseline + yearly medical 
and psychosocial 
examinations
61 allocated to intervention
13 drop-outs
19 drop-outs
Baseline + yearly medical 
and psychosocial 
examinations
Year 0-5
Year 1
Year 2-5
Figure 1. Flow chart of randomization and intervention processes.
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Table 3. Baseline psychosocial and demographic characteristics according to group 
assignment. Data are presented as no. (%) unless otherwise noted.
Intervention group 
(n=69)
Control group
(n=58)a
Socio economic index (1-5), mean (SD) 3.37  (1.5) 3.24  (1.2)
Education
-principal/elementary school 18  (26.1) 20  (34.5)
-upper school 19  (27.5) 10  (17.2)
-university/college 32  (46.4) 28  (48.3)
Employment (full- or part time) 54  (78.3) 42  (72.4)
Sickness absence (full- or part time) 45  (65.2) 31  (53.4)
Disability pension (full- or part time) 11  (15.9) 12  (21.1)
Self-rated health (1-5), mean (SD) 3.56  (1.0) 3.55  (0.9)
Quality of life (1-10), mean (SD) 5.12  (2.1) 5.62  (1.9)
Depression (BDI†, 0-63), mean (SD) 14.18 (9.3) 10.64 (7.5)
aThree women in the control group did not fill in the questionnaire.
Table 2. Baseline clinical characteristics according to group assignment. Data are presented 
as no. (%) unless otherwise noted.
Intervention group 
(n=69)
Control group 
(n=61)
Age (yrs), mean (SD) 52.5 (6.2) 54.3  (6.1)
BMI (kg/m2), mean (SD) 27.6 (5.1) 27.1  (4.5)
Systolic blood pressure (mmHg), mean (SD) 131  (17) 134  (20)
Smoking habits
-never 21  (30.4) 13  (22.4)
-current 20  (29.0) 14  (24.1)
-previous 28  (40.6) 31  (53.4)
History of AMI 47  (68.1) 39  (62.3)
History of PCI 27  (39.7) 30  (49.2)
History of CABG 12  (17.4) 16  (26.2)
Diabetes mellitus 10  (14.5) 11  (18.0)
Family history of CHDa 33  (47.8) 34  (57.6)
Post menopausalb 47  (68.1) 44  (72.2)
aDefined as first degree relative having had MI before the age of 60 yrs.
b
Defined as absence of menstrual cycle for ≥12 months before study entry.
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Study III
Out of 168 referrals, 19 dropped out and 149 were randomized. Furthermore, 6 women 
randomized to intervention and 13 to control group, decided not to participate shortly after 
randomization. For additional information about participants, see study II and flow chart 
(figure 1). Mortality and drop out rates are presented in table 4.
Exercise tests were performed after one, three and five years. The exercise capacity remained 
unchanged during the five years and no differences between the intervention and control 
group was found (figure 3).
Regarding psychosocial factors, no significant differences between the groups were found 
after five years (figure 4-6). Ten to fourteen years after study onset, QoL, measured with 
the “Ladder of Life”, was improved compared with baseline, but not with five years in both 
groups (figure 4). Trust in future QoL, was slightly decreased in both groups when compared 
with five years. However, the intervention group rated their future QoL as better than the 
controls (p= 0.05, figure 5). SRH was equally improved in both groups (figure 6).
**
(a) (b)
(c)
Figure 2. Emergency visits (a), scheduled doctor (b) visits to hospital and number of in-
patient days (c) during five years, according to group assignment (means). 
*p<0.05
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Table 4. Mortality and drop out rates between baseline and after 10-14 years.
Year
after
incl.
Intervention group Control group
n Drop outs Deceased n Drop outs Deceased
0 69 61
1 64 4 1 (from CVD) 55 6
3 64 50 5
5 60 4 (2 from CVD) 49 1
10-14 56 4 (2 from CVD) 43   8* (2 from CVD)
*Two of the deceased were former drop outs
Figure 4. Present Quality of Life at baseline, 
after 5 and 10-14 years. 1=worst possible 
life, 10=best possible life.
Figure 3. Exercise capacity (max Watt) at 
baseline, year 1, 3 and 5
.
Figure 6. Self rated health at baseline, 
after 5 and 10-14 years. 1=very bad health, 
5=very good health.
Figure 5. Future Quality of Life at baseline, 
after 5 and 10-14 years. 1=worst possible 
life, 10=best possible life.
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Study IV
Data were derived from the baseline examinations in study II and III. Out of the 130 women 
with CAD, 121 women completed the BDI and BAI questionnaires.
 
Twenty-three percent had BDI scores corresponding to moderate to severe depression (BDI 
>19). Scores >19 were strongly correlated to established angina pectoris (p<0.01) and higher 
rates of anxiety according to BAI (p<0.001) (table 5). Furthermore, women with low BDI 
showed very low rates of anxiety compared with more depressed women (p<0.01), indicating 
that anxiety is a noteworthy symptom in depressed women with CAD. Depressed women 
were also more likely to have a family history of heart disease (p<0.05) and were less likely 
to care about their future health (p<0.01).
Table 5. Baseline clinical and biochemical data for 121 women with CAD. All values are 
shown as mean (SD) unless otherwise noted.
Total sample
(N=121)
BDI <19
(n=93)
BDI 19-63
(n=28)c
p*
BMI 27.42 (4.81) 27.32 (4.85) 27.76 (4.72) 0.89
WHR, cm 0.84 (0.06) 0.84 (0.06) 0.85 (0.07) 0.54
Blood pressure, mm/Hg
 Systolic 132.23 (18.94) 133.4 (18.33) 128.36 (20.7) 0.25
 Diastolic 78.51 (9.78) 78.67 (9.59) 78.00 (10.55) 0.60
Diabetes mellitus, % 20 (16.5) 17.2 (16) 14.3 (4) 0.72
History of hypertension, % 50 (41.3) 38.7 (36) 50.0 (14) 0.29
Hyperlipedemia, % 81 (66.9) 64.5 (60) 75.0 (21) 0.30
Angina Pectoris, % 51 (42.1) 35.5 (33) 64.3 (18) <0.01
History of AMI, % 78 (64.5) 68.8 (64) 53.6 (15) 0.14
History of CABG, % 27 (22.3) 22.6 (21) 21.4 (6) 0.90
History of PCI, % 55 (45.5) 46.2 (43) 42.9 (12) 0.75
BDI 12.43 (8.63) 8.56 (4.98) 25.29 (4.88) <0.001
BAI 10.05 (8.31) 8.48 (7.07) 16.00 (9.68) <0.001
TC, mmol/l 4.77 (0.91) 4.78 (0.82) 4.75 (1.16) 0.49
HDL-C, mmol/l 1.32 (0.36) 1.33 (0.37) 1.27 (0.34) 0.52
LDL-C, mmol/l 2.71 (0.79) 2.71 (0.74) 2.71 (0.95) 0.85
TG, mmol/l 1.67 (0.84) 1.65 (0.82) 1.73 (0.94) 0.77
ApoB/A, g/l 0.82 (0.24) 0.82 (0.25) 0.82 (0.23) 0.73
Lipoprotein (a), g/l 0.33 (0.41) 0.32 (0.39) 0.34 (0.47 0.72
*Mann-Whitney U test
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GENERAL  DISCUSSION
This thesis studied two cohorts of women in Stockholm with CAD. The first study, KoK 
(Kvinnor och Kranskärlssjukdom), was initiated 1991 and the second study in 1997 “The 
Saltsjöbaden CR study” emanated from the experiences from the KoK study. The aim in the 
first study was to identify female risk factors for CAD. The experience was that few women 
were offered and participated in CR programs. Furthermore, the women who participated in 
the existing CR programs experienced that their individual needs not were considered. The 
programs were sometimes being described as a “men’s club” (Radley, Grove et al. 1998). The 
knowledge at that time was very scarce concerning CR in women; a meta-analysis showed 
that only a few women were included in all CR studies (Limacher 1998). 
Therefore, we aimed to create a CR program, adjusted for women. Initially four groups, each 
group comprising 6-9 patients, were recruited (some of them from the KoK study) as “pilot 
patients”. Their constructive criticism and ideas resulted in adjustments and a final program.
The women in the two studies were below retirement age since there was a need for more 
knowledge about CAD in younger women and, in the CR study, one aim was to study the 
impact of rehabilitation on sick-leave. There were high levels of sick leaves in Sweden, 
especially among women in the 1990’s. 
The KoK study comprised consecutive patients after an acute coronary event while 
recruitment procedure in the CR study followed the standard referral system. Thus, the latter 
sample might not be representative for female cardiac patients but rather for the group that 
is referred to and accepts participation in secondary prevention (Grace, Abbey et al. 2002; 
Witt, Jacobsen et al. 2004). The overall results from this study can therefore not necessarily 
be extrapolated to CAD-women in general. 
The women in the CR study had slightly higher level of education compared to the women 
in the KoK study. The women in the KoK study were slightly older but did not differ in BMI 
or systolic blood pressure, compared with the women in the CR study. The levels of total 
cholesterol and LDL were higher in the KoK-study which can be due to the existing therapy 
recommendations at the time. The percentage of current smokers was higher in the CR study 
for unknown reasons. Unfortunately, the attempts to reduce or stop smoking in the CR study 
evidently failed.
Exercise ECG tests were performed in both studies, mean exercise capacity were the same at 
baseline examination. Physical exercise has through the years been proven to be an important 
factor in the CR process. A follow up of mortality in the KoK study show that physical active 
life style was one of the most important factors for survival 9 years after coronary event 
(Study I). The CR study was not powered to predict mortality outcome.
The physical capacity, measured each year for 5 years in the CR study, remained unchanged. 
We expected the physical capacity to decline with increasing age. The women in the CR 
study (both interventions and controls) received optimal treatment with cardiac medications 
witch might be beneficial for physical capacity.
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In the CR study, no increase in BMI was found during 5 years of observation. This was 
unexpected since it has been shown by Kuskowska et al, that there is a steady increase with 
ageing among men in the prevalence of obesity, while women in menopausal age show a 
sharp weight gain (Kuskowska-Wolk and Rossner 1990).
Psychosocial factors including depression and anxiety have been shown to account for 
approximately 30% risk of AMI in the INTERHEART study (Rosengren, Hawken et al. 
2004). Women with CAD have more problems with depression and anxiety when compared 
with men, both before and after a myocardial infarction (Rosengren, Hawken et al. 2004).
The prevalence of moderate to severe depression, 25%, in study IV is in agreement with 
other studies. The women with depressive symptoms showed a higher frequency of anxiety 
symptoms, whereas the women who were not depressed showed low rates of anxiety. However, 
the major finding in study IV was the strong connection between depressive symptoms and 
angina pectoris. This link between depressive and anxiety symptoms and high frequency of 
angina pectoris indicates that these three symptoms can be misinterpreted by patients, health 
professionals and others (Katerndahl 1990; Korczak, Goldstein et al. 2007). Stress reducing 
CR programs including diagnostics for depression and anxiety may thus be useful in female 
CAD patients.
Stress management in cardiac rehabilitation has recently been reviewed. (Baumeister, Hutter 
et al. 2011). In 16 trials, psychological interventions showed a small beneficial effect on 
depression compared to usual care. No beneficial effects on mortality rates, cardiac events, 
cardiovascular hospitalizations and quality of life were found. Furthermore, no differences in 
treatment outcomes were found between the various psychological approaches. The review 
provides evidence of a small beneficial effect of pharmacological interventions with selective 
serotonin reuptake inhibitors (SSRIs). However, the evidence is scarce due to the low number 
of high quality trials and the heterogeneity of examined populations and intervention. 
However, Gulliksson et al (Gulliksson, Burell et al. 2011) found that CBT significantly 
reduced mortality and CVD reoccurrence in a mixed CAD population. In the largest study 
within the field, ENRICHED no major positive effects of CBT were found (Yusuf, Hawken 
et al. 2004). The conflicting results from different CBT studies suggest that more studies 
are needed in the area. The stress reducing method adopted from Moser et al (Moser and 
Björkegren 1998), used in our CR program, is a modified group-based cognitive behavior 
therapy. The program has not previously been evaluated in CAD patients.
During the follow up after 10-14 years, in our CR program a better hope for future quality of 
life were seen in the intervention group compared to the controls. Better self-rated health, less 
depressive symptoms and heart symptoms were found in both groups. 
This lack of differences between the interventions and controls may reflect the so called 
Hawthorne effect in the controls (McCarney, Warner et al. 2007). This term refers to the 
tendency to change behavior due to the special attention from research professionals.
The sample size in the CR study was small, which might explain why we were not able to 
show either morbidity/mortality effects, or major effects on psychosocial factors.
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One of the positive findings of the CR study was the reduced emergency health seeking 
in the intervention group. There were no effects on sick-leave or retirement, these results 
were in accordance with other studies (Lisspers, Hofman-Bang et al. 1999). Regarding 
health economy we were unable to perform such calculations because of the diverse types of 
conventional post-hospitalization care that the control group went through.
According to our experience and other studies, future CR for women should include detection 
and treatment of depression/anxiety, since these are of major importance for the prognosis.
Smokers evidently need better support and treatment than in our program. Smoking is a major 
independent cause of CAD among the causes of death for middle-aged and older women 
(Schmitz 2003). More research is needed to establish whether smoking cessation programs, 
targeted specifically for women can improve cessation rates.
Physical activity should be endorsed with emphasis on a daily basis, and be encouraged and 
followed up at every consultation.
It is impossible from the results of these studies to know whether CR should be residential, 
in out-patient clinics or home-based.
One positive effect of this CR program for women is that the program is still running in an 
ordinary clinical setting at Saltsjöbaden Hospital.
The experience from all personnel in our CR study was that the interplay and friendship 
within the women groups were extremely important factors. Still, after many years, the 
women continue to meet and support each other. 
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CONCLUSIONS
Women < 66 years with CAD were followed for 9 years. Important independent pre-• 
dictors of all-cause mortality were: sedentary life style, low physical fitness impaired 
pulse rate and SBP response during exercise.
In a randomized extensive 5 year rehabilitation program with CAD women <66 years, • 
visits at emergency wards were reduced in the intervention group compared to con-
trols. No differences between the groups were found in sick–leave, disability pensions, 
scheduled doctor’s visits and inpatient days during five years. Maximal exercise capac-
ity, blood pressure and pulse reaction were unchanged in both groups. No significant 
differences were found in psychosocial factors after five years.
Ten to fourteen years after study onset a better trust in future quality of life was found • 
in the intervention group compared with controls. Self-rated health and symptoms 
of depression were improved in both groups. Anxiety remained unchanged over the 
years.
The women with CAD in the CR study, both interventions and controls with completed • 
BDI questionnaire, were divided into 2 groups according to BDI-scores <19 or ≥ 19. 
The women with moderate to severe depression (BDI-score ≥ 19) had more symp-
toms of angina pectoris and were prescribed long acting nitrates more often even after 
adjusting for diabetes mellitus and smoking. High BDI-score was correlated to high 
scores of anxiety. Women with moderate to severe depressive symptoms rated their 
current health low and were more pessimistic about undertaking a healthy lifestyle in 
the future than those with BDI<19. Depressive symptoms and angina pectoris were 
correlated.
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